Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
44
# OF OVERLAPPING
HOLDINGS
SBIO
78
HOLDINGS
65%
ALSO IN XBI
XBI
139
HOLDINGS
33%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
AMICUS THERAPEUTICS INC | 3.0% | 1.6% | 1.6% |
|
CG ONCOLOGY, INC. | 3.5% | 1.5% | 1.5% |
|
MIRUM PHARMACEUTICALS, INC. | 3.1% | 1.5% | 1.5% |
|
CELCUITY INC. | 3.5% | 1.4% | 1.4% |
 |
ALKERMES PLC | 3.1% | 1.2% | 1.2% |
SBIO Overweight Relative to XBI
|
KYMERA THERAPEUTICS, INC. | 3.1% |
|
CRINETICS PHARMACEUTICALS INC | 2.4% |
|
CELCUITY INC. | 2.1% |
|
EDGEWISE THERAPEUTICS, INC. | 2.1% |
|
CG ONCOLOGY, INC. | 2.0% |
|
TARSUS PHARMACEUTICALS, INC. | 1.9% |
|
APOGEE THERAPEUTICS, INC. | 1.9% |
|
ALKERMES PLC | 1.8% |
|
MIRUM PHARMACEUTICALS, INC. | 1.7% |
|
SPYRE THERAPEUTICS INC | 1.6% |
SBIO Underweight Relative to XBI
|
MODERNA, INC. | -2.3% |
 |
ROIVANT SCIENCES LTD. | -1.8% |
|
ARCELLX, INC. | -1.7% |
|
VAXCYTE, INC. | -1.6% |
|
REVOLUTION MEDICINES, INC. | -1.6% |
|
GILEAD SCIENCES INC | -1.5% |
|
AMGEN INC | -1.5% |
|
UNITED THERAPEUTICS CORP | -1.4% |
|
BIOMARIN PHARMACEUTICAL INC | -1.4% |
|
VERTEX PHARMACEUTICALS INC | -1.3% |